Postpartum haemorrhage (PPH) is one of the top five causes of maternal mortality in developed and developing countries. The most important treatment of PPH is red blood cell (RBC) transfusion. The decision whether to prescribe RBC transfusion is mostly based on postpartum haemoglobin (Hb) values. RBC transfusion should be aimed to reduce morbidity and especially to improve Health Related Quality of Life (HRQoL). The goal of the WOMB study is to assess the effect of RBC transfusion on HRQoL and to confirm the role of HRQoL in deciding whether RBC transfusion is necessary.
The WOMB study is a multicenter trial in patients with PPH, where a restrictive RBC transfusion policy will be compared with a more liberal RBC transfusion policy. Primary outcome in this study is fatigue measured with the MFI questionnaire. Inclusion criteria are: 1) 12-24 h after VD or CS; 2) 4.8 ≤Hb≤ 7.9 g/dL; 3) blood loss ≥ 1000mL or Hb decrease ≥ 1,9 g/dL; 4) age≥ 18 years; 5) no anaemic symptoms. Patients will be randomised for a RBC transfusion or not. The total follow-up period is 6 weeks. HRQoL will be measured at T=0 (12-24 hours postpartum) 3 days, 1, 3 and 6 weeks postpartum. At T=0 and 6 weeks postpartum Hb value will be measured. For the patients who receive a RBC transfusion, the effect of the RBC transfusion will be measured with the Hb value, Hct, platelet and leukocyte count, and the temperature of the patient before and after the RBC transfusion. The sample size is 500 patients: 250 allocated to a RBC transfusion and 250 patients allocated to a restrictive policy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
500
At least one unit of red blood cells will be administered. The target Hb value after transfusion is at least 8.7 g/dL.
Sanquin Blood Bank South West Region
Rotterdam, Netherlands
Physical Fatigue
measured with the MFI questionnaire
Time frame: on day 3 postpartum
Health related quality of life
Health related quality of life measured with the following questionnaires: Euro-Qol, SF-36 and the MFI
Time frame: delivery - six weeks postpartum
Blood usage and the costs
Time frame: delivery - six weeks postpartum
Hemoglobin increase after transfusion
Hb value and platelet count will be measured before and after red blood cell transfusion
Time frame: before- after transfusion
Heart beat, blood pressure, temperature
heart beat per minute, blood pressure, temperature will be measured before and after red blood cell transfusion
Time frame: before- after transfusion
Hospital stay
the hospital stay after delivery will be compared between both arms. All admissions in the first 6 weeks postpartum will be registered
Time frame: delivery - six weeks postpartum
Physical complications (infections, thromboembolic events, hemodynamic events, cardiac events, neurologic events, secondary HPP, obstetric interventions, 'rescue' RBC transfusion) with WHO CTC grade 2 or more.
all complications and admissions in the first 6 weeks postpartum will be registered
Time frame: delivery - six weeks postpartum
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.